Endothelix, Inc.

Company Profile

 

Board of Directors and Advisors     Management Team     Scientific Advisory Board     Associated Research Fellows

 

 

Endothelix, Inc. is a cardiovascular device company focused on addressing the following two problems in a cost-effective manner:

  • Inaccurate individualized prediction of cardiovascular risk

  • Inadequate monitoring of the vascular response to treatments

The company’s first product is VENDYS®, a non-invasive, inexpensive, and easy to use vascular function test that aims to help physicians more accurately assess and monitor their patients’ cardiovascular health and use appropriate therapies for the prevention and treatment of heart disease and stroke.


The company originated in the Texas Medical Center-Houston from a collaborative project between the Texas Heart Institute and The University of Texas Health Science Center at Houston. Endothelix received a $1 million award from the Texas Emerging Technology Fund to develop the VENDYS® technology.


Endothelix has received FDA clearance for VENDYS® and is currently marketing the device to physicians and researchers.


The company has a pipeline of innovative products that will enable cardiovascular screening and monitoring, both in the doctor’s office as well as at home.

 

Interested Potential Investors Click Here

 

E-mail Address:

I would like to...


VENDYS® Presentation

View | Download

 

Testimonials

View

 

VENDYS® FAQ

View | Download

 

VENDYS® White Paper

View | Download

 

VENDYS® Movie

View